Study to Assess the Efficacy and Safety of NTRA-2112 on Intestinal Malabsorption in Preterm Infants

Clinical trial NCT02510560 · TERMINATED

Trial details

NCT number: NCT02510560
Sponsor: Elgan Pharma Ltd.
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Premature Birth of Newborn Intestinal Malabsorption

Start date: 2016-10-09
Primary completion: 2018-04-25
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.